Literature DB >> 21782639

Botanical health products, positioning and requirements for effective and safe use.

Aalt Bast1, R Frank Chandler, Patrick C Choy, Luc M Delmulle, Joerg Gruenwald, S Bart A Halkes, Konstantin Keller, Jan H Koeman, Paul Peters, Hildegard Przyrembel, Ellen M de Ree, Andrew G Renwick, Ingrid T M Vermeer.   

Abstract

Within the group of botanical products there is a large range of variation with regard to their properties. Some products are identical to foods while others come close to or are medicines. Botanical products are regulated differently within the different member states of the European Union (EU) and globally. They are regulated either as food or as medicinal products, and in the latter case often with simplified registration procedures. These differences are caused by differences in traditional use, in cultural and historical background, in scientific substantiation and in enforcement of current legislation. One may expect that in the future differences will remain, unless EU legislation is enacted with sufficient room for different approaches. The strengths and weaknesses of the different regulatory procedures have been reviewed and evaluated as well as the current methods for quality, efficacy and safety evaluation. Criteria to categorize botanical products have been defined, such that botanical products can be regulated under the current food and medicinal regulations. Furthermore, a decision tree has been developed as a tool to distinguish herbal medicinal products from botanical health products and vice versa, and to provide a stepwise framework for the assessment of safety and efficacy.

Year:  2002        PMID: 21782639     DOI: 10.1016/s1382-6689(02)00035-2

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  7 in total

1.  Toxicity assessment of Hypericum olympicum subsp. olympicum L. on human lymphocytes and breast cancer cell lines.

Authors:  Necmiye Balikci; Mehmet Sarimahmut; Ferda Ari; Nazlihan Aztopal; Mustafa Zafer Ozel; Engin Ulukaya; Serap Celikler
Journal:  J Appl Biomed       Date:  2020-02-20       Impact factor: 1.797

2.  Evaluation of extracts from Coccoloba mollis using the Salmonella/microsome system and in vivo tests.

Authors:  Marcela Stefanini Tsuboy; Juliana Cristina Marcarini; Dalva Trevisan Ferreira; Elisa Raquel Anastácio Ferraz; Farah Maria Drumond Chequer; Danielle Palma de Oliveira; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Genet Mol Biol       Date:  2010-09-01       Impact factor: 1.771

3.  A multi-criteria decision analysis model to assess the safety of botanicals utilizing data on history of use.

Authors:  T Neely; B Walsh-Mason; P Russell; A Van Der Horst; S O'Hagan; P Lahorkar
Journal:  Toxicol Int       Date:  2011-08

4.  Evaluation of genotoxicity of Euphorbia triaculeata Forssk. extract on mice bone marrow cells in vivo.

Authors:  Hanaa Mahmoud Mohamed; Magdy Sayed Aly
Journal:  Toxicol Rep       Date:  2018-05-18

5.  Modulation of atrazine-induced chromosomal aberrations and cyclin-dependent kinases by aqueous extract of Roylea cinerea (D.Don) Baillon leaves in Allium cepa.

Authors:  Farhana Rashid; Davinder Singh; Shivani Attri; Prabhjot Kaur; Harneetpal Kaur; Pallvi Mohana; Jahangeer Quadar; Adarsh Pal Vig; Astha Bhatia; Balbir Singh; Harpreet Walia; Saroj Arora
Journal:  Sci Rep       Date:  2022-07-22       Impact factor: 4.996

6.  Cancer Prevention and Health Benefices of Traditionally Consumed Borago officinalis Plants.

Authors:  María-Dolores Lozano-Baena; Inmaculada Tasset; Andrés Muñoz-Serrano; Ángeles Alonso-Moraga; Antonio de Haro-Bailón
Journal:  Nutrients       Date:  2016-01-18       Impact factor: 5.717

7.  THE EFFECTS OF Syzygium aromaticum-DERIVED TRITERPENES ON GASTROINTESTINAL GHRELIN EXPRESSION IN STREPTOZOTOCIN-INDUCED DIABETIC RATS.

Authors:  Mluleki Luvuno; Hlengiwe Prosperity Mbongwa; Andile Khathi
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.